Clinical Trials Browser

Completed × Observational × aldesleukin × Clear all

NCT00617799 2023-10-10

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT01288963 2023-06-15

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

Melanoma